New MRI-Guided radiation aims to zap abdominal tumors with fewer side effects

NCT ID NCT06604533

Recruiting now Disease control Sponsor: Australasian Gastro-Intestinal Trials Group Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using real-time MRI to guide radiation therapy can better control abdominal cancer that has spread to a few spots. Thirty adults with certain cancers (like colorectal or breast) will receive high-dose, precisely targeted radiation. The goal is to improve local tumor control while reducing damage to nearby organs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MRI-guided stereotactic adaptive radiotherapy (SABR)
What this could lead to: If successful, this approach could offer better tumor control and fewer side effects for people with abdominal cancer that has spread to a few spots.
What could go wrong: This is a small, early-phase trial with only 30 participants, so results may not apply to everyone. The treatment is complex and may still cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

digestive system cancer liver cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABDOMINAL CANCER

Contacts and locations

Locations

Austin Health
NOT_YET_RECRUITING

Melbourne, Victoria, 3084, Australia
GenesisCare - St Vincent's Sydney
RECRUITING

Darlinghurst, New South Wales, 2010, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.